Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, United States.
College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, United States.
Acta Biomater. 2019 Dec;100:173-183. doi: 10.1016/j.actbio.2019.09.026. Epub 2019 Sep 20.
Fibrillar collagens are highly prevalent in the extracellular matrix of all connective tissues and therefore commonly used as a biomaterial in tissue engineering applications. In the native environment, collagen fibers are arranged in a complex hierarchical structure that is often difficult to recreate in a tissue engineered construct. Small leucine rich proteoglycans as well as hyaluronan binding proteoglycans, aggrecan and versican, have been implicated in regulating fiber formation. In this study, we modified proteoglycan production in vitro by altering culture medium glucose concentrations (4500, 1000, 500, 250, and 125 mg/L), and evaluated its effect on the formation of collagen fibers inside tissue engineered meniscal constructs. Reduction of extracellular glucose resulted in a dose dependent decrease in total sulfated glycosaminoglycan (GAG) production, but minimal decreases of decorin and biglycan. However, fibromodulin doubled in production between 125 and 4500 mg/L glucose concentration. A peak in fiber formation was observed at 500 mg/L glucose concentration and corresponded with reductions in total GAG production. Fiber formation reduction at 125 and 250 mg/L glucose concentrations are likely due to changes in metabolic activity associated with a limited supply of glucose. These results point to proteoglycan production as a means to manipulate fiber architecture in tissue engineered constructs. STATEMENT OF SIGNIFICANCE: Fibrillar collagens are highly prevalent in the extracellular matrix of all connective tissues; however achieving appropriate assembly and organization of collagen fibers in engineered connective tissues is a persistent challenge. Proteoglycans have been implicated in regulating collagen fiber organization both in vivo and in vitro, however little is known about methods to control proteoglycan production and the subsequent fiber organization in tissue engineered menisci. Here, we show that media glucose content can be optimized to control proteoglycan production and collagen fiber assembly, with optimal collagen fiber assembly occurring at sub-physiologic levels of glucose.
纤维胶原在所有结缔组织的细胞外基质中都非常普遍,因此常被用作组织工程应用中的生物材料。在天然环境中,胶原纤维以复杂的层次结构排列,这在组织工程构建中往往难以重现。小富含亮氨酸的蛋白聚糖以及透明质酸结合蛋白聚糖、聚集蛋白聚糖和 versican 被认为参与调节纤维形成。在这项研究中,我们通过改变培养基葡萄糖浓度(4500、1000、500、250 和 125mg/L)来改变体外蛋白聚糖的产生,评估其对组织工程半月板构建体内部胶原纤维形成的影响。细胞外葡萄糖的减少导致总的硫酸化糖胺聚糖(GAG)产生剂量依赖性下降,但对 decorin 和 biglycan 的减少最小。然而,fibromodulin 在 125 至 4500mg/L 葡萄糖浓度之间的产量增加了一倍。在 500mg/L 葡萄糖浓度下观察到纤维形成的峰值,并且与总 GAG 产量的降低相对应。在 125 和 250mg/L 葡萄糖浓度下纤维形成减少可能是由于与葡萄糖供应有限相关的代谢活性变化所致。这些结果表明蛋白聚糖的产生是一种在组织工程构建体中操纵纤维结构的手段。意义陈述:纤维胶原在所有结缔组织的细胞外基质中都非常普遍;然而,在工程化的结缔组织中实现适当的胶原纤维组装和组织仍然是一个持续存在的挑战。蛋白聚糖已被认为在体内和体外调节胶原纤维组织,但是对于控制蛋白聚糖产生和组织工程半月板中随后的纤维组织的方法知之甚少。在这里,我们表明可以优化培养基葡萄糖含量来控制蛋白聚糖产生和胶原纤维组装,最佳胶原纤维组装发生在低于生理水平的葡萄糖浓度下。